Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan flag Japan · Delayed Price · Currency is JPY
5,332.00
+99.00 (1.89%)
May 13, 2025, 3:30 PM JST

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 32.61B JPY in the quarter ending March 31, 2025, a decrease of -10.63%. This brings the company's revenue in the last twelve months to 161.72B, down -8.36% year-over-year. In the year 2024, Kobayashi Pharmaceutical had annual revenue of 165.60B, down -4.53%.

Revenue (ttm)
161.72B
Revenue Growth
-8.36%
P/S Ratio
2.41
Revenue / Employee
44.74M
Employees
3,615
Market Cap
389.02B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024165.60B-7.86B-4.53%
Dec 31, 2023173.46B7.20B4.33%
Dec 31, 2022166.26B11.01B7.09%
Dec 31, 2021155.25B4.74B3.15%
Dec 31, 2020150.51B-17.54B-10.44%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Japan Tobacco 3,236.41B
Seven & i Holdings 10.34T
Ajinomoto Co. 1,530.56B
Asahi Group Holdings 2,939.42B
Kao Corporation 1,652.51B
Pan Pacific International Holdings 2,176.10B
Unicharm 980.22B
Kirin Holdings Company 2,338.39B
Revenue Rankings